Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
3,252
+46
+1% +$15.7K 0.43% 52
2026
Q1
$1.13M Buy
3,206
+38
+1% +$13.5K 0.46% 49
2025
Q4
$1.04M Buy
3,168
+1
+0% +$317 0.43% 49
2025
Q3
$894K Buy
3,167
+17
+0.5% +$4.93K 0.38% 62
2025
Q2
$879K Buy
3,150
+4
+0.1% +$1.13K 0.4% 58
2025
Q1
$980K Sell
3,146
-19
-0.6% -$5.61K 0.48% 49
2024
Q4
$825K Buy
3,165
+1
+0% +$297 0.4% 56
2024
Q3
$1.02M Hold
3,164
0.53% 43
2024
Q2
$989K Hold
3,164
0.57% 40
2024
Q1
$900K Sell
3,164
-1,737
-35% -$508K 0.59% 42
2023
Q4
$1.41M Buy
+4,901
New +$1.34M 1% 25

Other funds holding AMGN

Burford Brothers's AMGN Position: Q2 2026 in Review

Burford Brothers increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $15.7K and bringing the position to 3,252 shares worth $1.18M. The position accounts for 0.43% of the portfolio, ranked #52.

Burford Brothers first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.41M in Q4 2023. 3,144 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Burford Brothers held 3,252 shares of Amgen worth $1.18M as of Q2 2026.
  • Burford Brothers bought 46 Amgen shares in Q2 2026, an estimated $15.7K.
  • Amgen made up 0.43% of Burford Brothers's portfolio in Q2 2026, its #52 holding.
  • Burford Brothers first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Burford Brothers's Amgen position peaked at $1.41M in Q4 2023.
  • 3,144 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.